New England Research & Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,350
Closed -$272K 152
2017
Q3
$272K Buy
+5,350
New +$286K 0.2% 127
2015
Q3
Sell
-5,100
Closed -$328K 161
2015
Q2
$328K Buy
+5,100
New +$312K 0.27% 122

Other funds holding ALKS

New England Research & Management's ALKS Position: Q4 2017 in Review

New England Research & Management sold out of Alkermes (ALKS) in Q4 2017, closing a stake of 5,350 shares — an estimated $272K sold.

New England Research & Management first reported a position in ALKS in Q2 2015 and held it in 2 quarters. The position peaked at $328K in Q2 2015. 248 funds tracked by Wall St. Rank hold ALKS as of Q4 2017.

  • New England Research & Management reported no remaining Alkermes position as of Q4 2017 after selling out during the quarter.
  • New England Research & Management sold 5,350 Alkermes shares in Q4 2017, an estimated $272K.
  • New England Research & Management first reported a position in Alkermes in Q2 2015 and held it in 2 quarters.
  • New England Research & Management's Alkermes position peaked at $328K in Q2 2015.
  • 248 funds tracked by Wall St. Rank held Alkermes as of Q4 2017.

Based on New England Research & Management's 13F filing for Q4 2017, filed 9 Jan 2018.